Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-13

Clinical Trial Update: Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pasireotide as maintenance therapy in Desmoplastic Small Round Cell Tumor and Synovial Sarcoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pasireotide (pasireotide)

Snippet

Sponsor: University Hospital Heidelberg | Conditions: Desmoplastic Small Round Cell Tumor, Synovial Sarcoma | Phase 2 | Status: RECRUITING